Evidence map›Paper›PMID 37662926›Full record

ReviewFrontiers in immunology2023

Immune responses to

Thomas Belcher, Christine S Rollier, Christina Dold, Jonathan D C Ross, Calman A MacLennan

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07758972 (A First in Human Phase I Randomized and Controlled Trial to Test Safety and Immunogenicity of a Multivalent Vaccine Against Neisseria Gonorrhoeae), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07758972 phase1recruitingnot on this mapstarted 2026, after this paper: background citation

A First in Human Phase I Randomized and Controlled Trial to Test Safety and Immunogenicity of a Multivalent Vaccine Against Neisseria Gonorrhoeae

TypeinterventionalSponsorLimmaTech Biologics AGRan2026 to 2027Enrolled142ConditionsNeisseria GonorrheaArmsLTB-NG6, Sodium Chloride 0.9%
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Diversity and evolution of a phase-variable multi-locus antigen inbioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Frontiers in microbiology · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thomas BelcherJenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Christine S RollierSchool of Biosciences, University of Surrey, Guilford, United Kingdom.
Christina DoldThe Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Jonathan D C RossSexual Health and HIV, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom.
Calman A MacLennanJenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
University of Oxford · GBUniversity of Surrey · GB

Funding

2016 SETAC Asia/Pacific ConferenceR13ES027302 · NIEHS · SOCIETY/ENVIRONMENTAL TOXICOLOGY/CHEM · PI MENZIE, CHARLES · 2016 to 2016
$6k
NIEHS NIH HHS 27302C0028Wellcome TrustWellcome Trust WT224842
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GonorrheaSex WorkersAnimalsCross ProtectionDisease Models, AnimalFemaleHumansMaleMiceNeisseria gonorrhoeaeVaccine DevelopmentgonococcusgonorrheaimmunologyNeisseriaSTIvaccines

Identifiers

PMID37662926
PMCPMC10470030
OpenAlexW4385982798

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.